A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
about
Management of involuntary childlessness.Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results.Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORSHyperprolactinaemia - a problem in patients from the reproductive period to the menopause.Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach.Cabergoline-induced Mania in a Patient of Pituitary MicroadenomaManagement of macroprolactinomas.Menstrual Cycle Abnormalities in Patients with Prolactinoma and Drug-induced HyperprolactinemiaPotential of gene therapy for the treatment of pituitary tumorsCabergoline associated with first episode maniaThe effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor.Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.Prolactinoma and pregnancy.Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor.Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.Dopamine receptor agonists for treating prolactinomas.Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy.Treatment of prolactinomas in low-income countries.The treatment of sporadic versus MEN1-related pituitary adenomas.Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.Diagnosis and management of hyperprolactinemia.Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy.Recovery pattern of hypothalamo-pituitary-testicular axis in patients with macroprolactinomas after treatment with cabergoline.Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adultsDoes Twice-weekly Cabergoline Improve Anthropometrical and Biochemical Profiles in Prediabetes? A Randomized Double-blind Clinical Trial Pilot Study.Medical management of functioning pituitary adenoma: an update.Managing prolactin-secreting adenomas during pregnancy.Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experienceThe effect of cabergoline on clinical and laboratory findings in active rheumatoid arthritis.Effect of dopaminergic drug treatment on surgical findings in prolactinomas.Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.Treatment of hyperprolactinemia: a systematic review and meta-analysis.Vanishing tumor in pregnancy.Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.Prolactin-secreting tumors: what's new?
P2860
Q24534316-194FAD0A-871B-487D-8C8E-846F0DD3E9CFQ30299965-381FBEBA-C87A-42C6-9A52-6085395E1639Q31980098-DDD83F6B-B55F-4EE3-AD28-F4E7D9D101FFQ33674877-561BAF69-AB31-4068-B585-6B0FEA6DEE8DQ33704842-A1BEB231-7381-4AE3-93FB-DD85B80CA8AAQ33721266-F549D94D-4C53-4F01-8ACF-00E1B1746908Q33772064-B83C65F1-C766-44C4-B7A8-0DFF59134410Q33792371-A1192364-7166-48A0-9040-11C46C8C79D4Q33815513-EF80833B-6089-430E-914B-1A159E7B32C6Q33899750-80E15A15-D5F6-439E-93D2-DB045A69571EQ33901882-340BA274-41DE-4F53-92BD-69E716F60710Q33912655-0E49B240-2192-4597-8EBD-9ABEFE2171E7Q33954437-5CB43DDE-1121-4974-B6D1-F1F07B82429EQ33985606-83096F68-33C6-4188-80DC-E297B87FA990Q34043810-80DB85C6-7B77-40EF-8F67-1193703EE709Q34182721-A2BB5395-AB84-401D-B59D-B86E01A3463EQ34560466-9830D84A-9805-4B98-9CA9-987A5FC0D632Q34638272-E595DB91-4F84-46EF-BFB9-9520D2D5CA8BQ34660851-83E392AF-9806-42C1-889B-63105F567116Q35022245-566BB5A2-B92C-43B3-A4C0-A1E1F1765630Q35106933-AAB38E74-CD1A-432A-B366-14DA8EE7C64BQ35109902-6631265B-5DCE-4034-A388-01AFD76E1AA1Q35130896-E1C2722E-22A6-4CE0-A2FF-3C8A9F287F19Q35137687-8B421B5E-0F0F-4C1D-9C7D-283C3EDD5339Q35219497-2D4F6B20-C19F-41AC-8A37-BFFEA0922200Q35244492-D327934E-9D04-49AB-B388-9274195E9233Q35351817-817C7C6B-01FC-46EB-9A99-55171F79666AQ35589236-77812D81-F05F-4236-A521-BDDCECCF7C70Q35791125-6B5CFF86-B323-4D44-A2D5-39926CCCD625Q35843293-0CB3FE1C-B5E3-4D51-84AD-B11FD28CF7A5Q35943493-0584F9FD-F689-42E8-9D54-2EBC0668422AQ35951385-93D313B3-483D-4EF2-96C9-3C4576A1A719Q36011347-E093988E-BEA3-4ED0-A352-F3B1922F440CQ36022199-9A2A997A-E823-47FD-AE1C-D7B4A0EB1E07Q36182003-2CCD2A45-4919-4B42-A161-784F8B319D10Q36266376-23ADA0C1-D10C-4312-A33A-5FB1402EC773Q36355322-9F690265-3A42-40CC-87A5-FA1A9690EA1EQ36436429-4B4B277E-C77A-4130-98E6-E9A952DEBFA9Q36530336-BBC47F9A-234E-4AEC-9666-E6BB30B18BE1Q36605350-A438B89A-088A-4576-8075-0793E7347129
P2860
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A comparison of cabergoline an ...... oline Comparative Study Group.
@ast
A comparison of cabergoline an ...... oline Comparative Study Group.
@en
A comparison of cabergoline an ...... oline Comparative Study Group.
@nl
type
label
A comparison of cabergoline an ...... oline Comparative Study Group.
@ast
A comparison of cabergoline an ...... oline Comparative Study Group.
@en
A comparison of cabergoline an ...... oline Comparative Study Group.
@nl
prefLabel
A comparison of cabergoline an ...... oline Comparative Study Group.
@ast
A comparison of cabergoline an ...... oline Comparative Study Group.
@en
A comparison of cabergoline an ...... oline Comparative Study Group.
@nl
P2093
P1476
A comparison of cabergoline an ...... oline Comparative Study Group.
@en
P2093
P304
P356
10.1056/NEJM199410063311403
P407
P577
1994-10-01T00:00:00Z